Back to Search Start Over

PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.

Authors :
Stebbing J
Ellis P
Tutt A
Source :
Future oncology (London, England) [Future Oncol] 2010 Apr; Vol. 6 (4), pp. 485-6.
Publication Year :
2010

Subjects

Subjects :
Female
Humans
Antineoplastic Agents therapeutic use
BRCA1 Protein genetics
BRCA2 Protein genetics
Breast Neoplasms drug therapy
Breast Neoplasms genetics
Enzyme Inhibitors therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors

Details

Language :
English
ISSN :
1744-8301
Volume :
6
Issue :
4
Database :
MEDLINE
Journal :
Future oncology (London, England)
Publication Type :
Editorial & Opinion
Accession number :
20373860
Full Text :
https://doi.org/10.2217/fon.10.27
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details